Skip to main content
. 2022 Feb 22;39(4):1754–1771. doi: 10.1007/s12325-022-02060-1

Fig. 5.

Fig. 5

Use of rescue medication in the 3 years after treatment initiation in patients with NETs. Rescue medication was defined as a short-acting SSA. **p < 0.001; calculated using the chi-squared test. LAN lanreotide autogel, OCT octreotide long-acting release, SSA somatostatin analogue